BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15104009)

  • 1. Three-dimensional LET calculations for treatment planning of proton therapy.
    Wilkens JJ; Oelfke U
    Z Med Phys; 2004; 14(1):41-6. PubMed ID: 15104009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in linear energy transfer within clinical proton therapy fields and the potential for biological treatment planning.
    Grassberger C; Trofimov A; Lomax A; Paganetti H
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1559-66. PubMed ID: 21163588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of radiobiological effects in intensity modulated proton therapy.
    Wilkens JJ; Oelfke U
    Med Phys; 2005 Feb; 32(2):455-65. PubMed ID: 15789592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code.
    Guan F; Peeler C; Bronk L; Geng C; Taleei R; Randeniya S; Ge S; Mirkovic D; Grosshans D; Mohan R; Titt U
    Med Phys; 2015 Nov; 42(11):6234-47. PubMed ID: 26520716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analytical dose-averaged LET calculation algorithm considering the off-axis LET enhancement by secondary protons for spot-scanning proton therapy.
    Hirayama S; Matsuura T; Ueda H; Fujii Y; Fujii T; Takao S; Miyamoto N; Shimizu S; Fujimoto R; Umegaki K; Shirato H
    Med Phys; 2018 Jul; 45(7):3404-3416. PubMed ID: 29788552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
    Giantsoudi D; Adams J; MacDonald SM; Paganetti H
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of linear energy transfer computed in a Monte Carlo dose engine of a commercial treatment planning system.
    Wagenaar D; Tran LT; Meijers A; Marmitt GG; Souris K; Bolst D; James B; Biasi G; Povoli M; Kok A; Traneus E; van Goethem MJ; Langendijk JA; Rosenfeld AB; Both S
    Phys Med Biol; 2020 Jan; 65(2):025006. PubMed ID: 31801119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.
    Henry T; Ödén J
    Phys Med; 2018 Dec; 56():81-89. PubMed ID: 30473384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linear energy transfer-guided optimization in intensity modulated proton therapy: feasibility study and clinical potential.
    Giantsoudi D; Grassberger C; Craft D; Niemierko A; Trofimov A; Paganetti H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):216-22. PubMed ID: 23790771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical calculation of proton linear energy transfer in voxelized geometries including secondary protons.
    Sanchez-Parcerisa D; Cortés-Giraldo MA; Dolney D; Kondrla M; Fager M; Carabe A
    Phys Med Biol; 2016 Feb; 61(4):1705-21. PubMed ID: 26840945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios.
    Giovannini G; Böhlen T; Cabal G; Bauer J; Tessonnier T; Frey K; Debus J; Mairani A; Parodi K
    Radiat Oncol; 2016 May; 11():68. PubMed ID: 27185038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can differences in linear energy transfer and thus relative biological effectiveness compromise the dosimetric advantage of intensity-modulated proton therapy as compared to passively scattered proton therapy?
    Giantsoudi D; Adams J; MacDonald S; Paganetti H
    Acta Oncol; 2018 Sep; 57(9):1259-1264. PubMed ID: 29726722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.
    An Y; Shan J; Patel SH; Wong W; Schild SE; Ding X; Bues M; Liu W
    Med Phys; 2017 Dec; 44(12):6138-6147. PubMed ID: 28976574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards harmonizing clinical linear energy transfer (LET) reporting in proton radiotherapy: a European multi-centric study.
    Hahn C; Ödén J; Dasu A; Vestergaard A; Fuglsang Jensen M; Sokol O; Pardi C; Bourhaleb F; Leite A; de Marzi L; Smith E; Aitkenhead A; Rose C; Merchant M; Kirkby K; Grzanka L; Pawelke J; Lühr A
    Acta Oncol; 2022 Feb; 61(2):206-214. PubMed ID: 34686122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic approach for calibrating a Monte Carlo code to a treatment planning system for obtaining dose, LET, variable proton RBE and out-of-field dose.
    Tjelta J; Fjæra LF; Ytre-Hauge KS; Boer CG; Stokkevåg CH
    Phys Med Biol; 2023 Nov; 68(22):. PubMed ID: 37820690
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical dose assessment for scanned carbon-ion radiotherapy using linear energy transfer measurements and Monte Carlo simulations.
    Nakaji T; Kanai T; Takashina M; Matsumura A; Osaki K; Yagi M; Tsubouchi T; Hamatani N; Ogawa K
    Phys Med Biol; 2022 Dec; 67(24):. PubMed ID: 36327456
    [No Abstract]   [Full Text] [Related]  

  • 17. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer.
    Pedersen J; Petersen JBB; Stokkevåg CH; Ytre-Hauge KS; Flampouri S; Li Z; Mendenhall N; Muren LP
    Acta Oncol; 2017 Nov; 56(11):1413-1419. PubMed ID: 29037095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Monte Carlo based radiation response modelling framework to assess variability of clinical RBE in proton therapy.
    Eulitz J; Lutz B; Wohlfahrt P; Dutz A; Enghardt W; Karpowitz C; Krause M; Troost EGC; Lühr A
    Phys Med Biol; 2019 Nov; 64(22):225020. PubMed ID: 31374558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
    Traneus E; Ödén J
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.